Keywords: Liquisolid compacts, Mefenamic acid, Liquid retention potential (Ø), Avicel-PH 102, Aerosil 200, drug release kinetics.
|
|
- Donna Page
- 6 years ago
- Views:
Transcription
1 International Journal of Pharmaceutical Development & Technology e ISSN X Print ISSN FORMULATION AND EVALUATION OF MEFENAMIC ACID EXTENDED RELEASE LIQUISOLID TABLETS CH.Pradeep Kumar* 1, P.Venugopalaiah, CH. Praveen Kumar, K. Gnanaprakash, M. Gobinath 1 Department of Pharmaceutics, Ratnam Institute of Pharmacy, SPSR Nellore, Andhra Pradesh, India ABSTRACT Liquisolid system refers to formulations formed by conversion of liquid drugs, drug suspension or drug solution in nonvolatile solvents in to non-adherent, free flowing and compressible powder mixtures by blending the solution or suspension with selected carriers and coating materials. The aim of the present work was to formulate and evaluate extended liquisolid compacts of Mefenamic acid. Liquisolid extended formulations were prepared by using HPMC K100M as adjuvant for extended. Different liquisolid compacts were prepared using a mathematical model to calculate the required quantities of powder and liquid ingredients to produce acceptable and free flowing compressible mixtures. Avicel PH 102, Aerosil-200 were employed as carrier and coating materials. The prepared liquisolid compacts were evaluated for their flow properties such as bulk density, tapped density, angle of repose, Carr s compressibility index, Hausner s ratio. Drug-excipients interactions were studied by FT-IR. Drug rates of liquisolid compacts shows significant benefit and distinct profiles when compared to normal extended tablets and from the results it was concluded that at higher amount of Aerosil 200 (Batch F12), drug was found to be retarded as compared to other batches. Increase in concentration of HPMC K100M might be responsible to get extended effect. The obtained data of liquisolid compacts were fitted into several mathematical models such as Zero order, First order, Higuchi, Korsemayer-Peppas, and the obtained data was fitted into zero order pattern followed by non-fickian transport mechanism. Drug profiles on model fitting follow Peppas model as best fit model which indicates drug diffusion in hydrated matrix and polymer relaxation. Keywords: Liquisolid compacts, Mefenamic acid, Liquid retention potential (Ø), Avicel-PH 102, Aerosil 200, kinetics. INTRODUCTION The oral route is the preferred route for the chronic drug therapy. Numerous potent lipophilic drugs exhibit low oral bioavailability due to their poor aqueous solubility properties. Therapeutic effectiveness of a drug depends up on the bioavailability and ultimately upon the solubility and dissolution rate molecules. Solubility and dissolution rate are the important parameters to achieve desired concentration in systemic circulation for pharmaceutical response to be shown [1]. BCS class II drugs pose challenging problems in their pharmaceutical product development process because of their low solubility and dissolution rates. They require enhancement in solubility and dissolution rate in their formulation development especially solid dosage forms such as tablets and capsules. More recently, powdered solution (liquisolid) technology has been proposed as a technique for the delivery of water-soluble drugs. The concept of powdered solutions involves converting drug solutions or liquid drugs into a dry, non-adherent, free-flowing compressible powder by admixturing the liquid drugs or drug solutions with a selected carrier. Although the dosage form is a solid, the drug was held in a solubilized liquid state, which enhances diffusion directly into cells. Alternatively, improves the wetting properties of the drug and therefore enhanced dissolution [2]. Since drug dissolution is often the rate limiting step in gastrointestinal absorption, the significant increase in wetting properties and surface area particles available for dissolution from liquisolid compacts may be expected to display enhanced characteristics and, consequently, improved oral bioavailability. The technique of liquisolid compacts has been successfully employed to improve the In Vitro of poorly water soluble drugs such as Carvidilol [3], Corresponding Author :- CH.Pradeep Kumar - deepuu75@gmail.com 80 P a g e
2 Bromhexine Hydrochloride [4], Furosemide [5], carbamazepine [6], Fenifibrate [7], Indomethacin [8], Aceclofenac [9], ketoprofen [10], theophylline [11], propranolol hydrochloride [12], Lansoprazole [13], Irbesartan [14], Lornoxicam [15], simvastatin [16], tramadol hydrochloride [17], and fenofibrate [18]. Mefenamic acid is one of the Anthranilic acid derivatives of Non-Steroidal Anti-Inflammatory Drugs (NSAID). Recent clinical studies on Mefenamic acid revealed that the drug is an effective agent for accumulation and moderate to severe ulceration in GI tract. Repeated administration of high doses of mefenamic acid ( mg- 3 s/day) leads to accumulation in GIT causes Inflammatory bowel diseases, peptic ulcers, and also due to its sudden causes local irritation in the stomach which is a major limitation for mefenamic acid as conventional dosage form, and its less half-life period (< 2hrs). To reduce frequent administration of dosage form and to improve patient compliance extended liquisolid mefenamic acid formulation is desirable. Hence the main objective of this work was to retard/sustain the from the dosage form to eliminate the repeated administration and also to increase the half-life of mefenamic acid in GI environment. In the present study, Hydroxy Propyl Methyl Cellulose (HPMC) K100M was used as adjuvant for sustaining the from liquisolid compacts. Poly Ethylene Glycol (PEG-400) was used as non-volatile lipophilic solvent. Avicel PH 102 (Microcrystalline cellulose), Pregelatinized Starch and Aerosil 200 (Colloidal silicon dioxide) were used as carrier and coating materials, respectively. Precompression studies such as determination of angle of slide, Hausner s ratio, Carr s index and stereomicroscopic analysis was also studied. The discrimination of profiles was compared with normal extended tablets of Mefenamic acid (without liquid lipophilic solvent and Aerosil 200). Model fitting of the results was also done for different models such as Zero order, First order, Higuchi plot and Korsemayer-Peppas plot models. The formulation design of liquisolid systems was done in accordance with new mathematical model described by spireas et al., [19]. MATERIALS AND METHODS Materials Mefenamic acid was obtained from Alexo pharma (India). HPMC K100M, Avicel PH-102, Starch pregelatinized, Aerosil 200 were purchased from Drugs India Pvt ltd (India). Poly ethylene glycol 400 was obtained from Fischer scientific. All the ingredients and chemicals utilized were of analytical grade. Methods Application of mathematical model for design of Liquisolid compacts Before designing the liquisolid system, the preformulation studies should be performed first, includes Carrier-Coating material ratio (R) Determination of flowable liquid retention potential (Ø value) Calculation of liquid load factor (L f ) Liquid solid compressibility test (LSC) The flowability and compressibility of liquisolid compacts are addressed concurrently in the new formulation mathematical model of liquisolid systems, which was used to calculate the appropriate quantities of the carrier and coating materials required to produce acceptably flowing and compressible powders based on new fundamental powder properties called the flowable liquid retention potential (Ø value) and compressible liquid retention potential (Ψ value) of the consistent powders [20, 21]. Carrier-Coating material ratio (R) It is the ratio between the quantities of carrier (Q) and coating (q) present in the formulation. It is represented as R=Q/q Determination of flowable liquid retention potential (Ø) It is defined as maximum weight of liquid that can be retained per unit powder material in order to produce an acceptably flowing liquid/powder admixture. This Ø-value of powders may be determined using a new procedure, the liquisolid flowability (LSF) test. This test is basically a titration-like procedure in which grams of mixtures of the powders under investigation, with increasing amounts of a non-volatile solvent (i.e., liquid/solid weight composition), such as, for example, poly ethylene glycol, light mineral oil and clofibrate, are prepared using a standard mixing process which ensures uniformity, and their flow rate and consistency are assessed using a recording powder flow meter (RPF) [19, 22, 23]. Lf= Ø CA + Ø CO (1 / R) Where, Ø and Ø are the constant liquid retention potential values of carrier and coating materials, respectively. By calculating L f and W, we can calculate the Q and q required for liquisolid systems [24]. Calculation of liquid load factor (L f ) It is defined as ratio of weight of liquid medication (W) to weight of carrier material (Q). Different concentrations of nonvolatile solvents are taken and the drug is dissolved and the carrier coating material is added and blended. L f =W/Q Where W is ratio of weight of liquid medication and Q is weight of carrier material [25]. By use of above mathematical model, liquisolid compacts were formulated. Formulation of Mefenamic acid Liquisolid compacts Mefenamic acid liquisolid tablet preparation method involves, first a mathematically calculated amount of pure drug was weighed and dissolved in the suitable amount of lipophilic liquid vehicle in a molecularly 81 P a g e
3 dispersed state. For attaining good flow properties trial and error methods were used i.e. changing the carrier: coating ratio from 50:1 to 5:1 ratios according to new mathematical model expressions proposed by Liao [26]. This liquid medication is poured on the suitable amount of carrier material. The liquid medication is absorbed into the carrier internally and externally. Finally, coating material was added for dry looking, adherent to the carrier material for achieving good compression properties. Liquid medication is incorporated into carrier material which has a porous surface and closely matted fibers in its interior as cellulose [20]. Both absorption and adsorption takes place, i.e. the liquid absorbed into the interior of the particles is captured by its internal structure and after saturation of this process, adsorption of the liquid onto the internal and external surface of the porous carrier particles occurs. According to the above mathematical model calculated quantities of Mefenamic acid and propylene glycol 400 was accurately weighed in 20 ml glass beaker and then heated to 80 C. Resulting hot medication was incorporated into calculated quantities of carrier and coating materials. Mixing process is carried out in three steps as described by Spireas et al., During first stage, system was blended at an approximate mixing rate of one rotation per second for approximately one minute in order to evenly distribute liquid medication in the powder. In second stage, the liquid/powder admixture was evenly spread as a uniform layer on the surfaces of mortar and left standing for approximately 5 min to allow drug solution to be absorbed in the interior of powder particles. In third stage, powder was scraped off the mortar surfaces by means of aluminum spatula and then blended with HPMC K100M, for another 30 seconds in a similar to first stage. This gives final formulation of liquisolid tablets. Prepared liquisolid formulation was compressed by 16 station Rotary tablet punching machine (Cadmach). EVALUATION Standard graph for Mefenamic acid Step 1: Preparation of standard stock solution: An accurately weighed quantity of 100 mg of mefenamic acid was taken in a 100 ml standard flask. To this equal volume of 0.1N HCl was added and made up to the volume. Step 2: Preparation of sample solution: Different aliquots (0.0, 0.5, 1.0,, 5.5 ml) of Mefenamic acid solution were accurately measured from the above primary stock and transferred into a series of 100 ml volumetric flasks and volume made up to the mark with 0.1 M HCl. Then all dilutions were scanned by UV Spectrophotometer at 285nm against blank and the results were tabulated and a plot was drawn between concentration (µg/ml) on x-axis and absorbance (nm) over y-axis. Determination of Solubility of Mefenamic acid in various lipophilic solvents Saturated solutions were prepared by adding excess of Mefenamic acid to different lipophilic solvents includes Propylene glycol, PEG-400, Sorbitan esters ( Span-80, Span-60, Tween-80, Tween-60, Tween-20, Glycerin, SLS- 10%) and shaking on the shaker for 48 h at 25 C under constant vibrations. The solutions were filtered through a 0.40 micron filter, after this, the solutions are filtered, diluted and analyzed spectrophotometrically at 285 nm against blank sample (blank sample was solution containing same concentration of used without drug). Three determinations were carried out for each sample to calculate the solubility of Mefenamic acid. Drug-Excipient compatibility study: FT-IR spectroscopy FT-IR patterns were studied by Shimadzu 8400S, Japan FT-IR spectrometer. The samples (Mefenamic acid and Excipients) were previously ground and mixed thoroughly with potassium bromide, an infrared transparent matrix, at 1:5 (Sample: KBr) ratio, respectively. The KBr discs were prepared by compressing the powders at a pressure of 5 tons for 5 min in a hydraulic press. The scans were obtained at a resolution of 4 cm -1, from 4000 to 400 cm -1. Pre-compression evaluation studies Pre-formulation studies such as bulk density, tapped density, angle of repose, compressibility index, Hausner s ratio were performed for drug alone and liquisolid compressible powders as per the standard procedures and the results were tabulated in table-3 [27-29]. Post-compression evaluation parameters After compression of desired doses and its excipients into suitable tablet dosage form, each batch was subjected to the following evaluation parameters such as Weight variation, Friability, Tablet dimensions, Drug content analysis, Hardness and In-vitro studies according to the standard pharmacopoeial procedures [28, 29]. In-vitro dissolution studies The studies were done on eight station USP dissolution apparatus I (Lab India). All batches of tablets were evaluated using 900 ml of sequential gastrointestinal medium, i.e. 0.1N hydrochloric acid (ph 1.2) for first two hours, acetate buffer of ph 4.5 for next 2 hrs and then phosphate buffer of ph 7.4 for 8 hours. Temperature was maintained at 37 ± 0.5 C throughout the study and stirring at 50 rpm was carried out. Samples were collected periodically, filtered through 0.45 micron filter and replaced with fresh dissolution medium. After filtration Samples were properly diluted and Mefenamic acid concentrations were analyzed spectrophotometrically at 285 nm. The d at interval was calculated and plotted against. Mathematical modeling for profile 82 P a g e
4 The cumulative amount of Mefenamic acid d from the formulated tablets at different intervals were fitted in to several kinetic models such as Zero order kinetics, First order kinetics, Higuchi model and Korsemayer-peppas model to characterize mechanism of. Zero order kinetics It describes the system in which the rate is independent of its concentration. Q t = Q 0 +K 0 t Where, Q t = amount dissolved in t Q 0 = initial amount in the solution K 0 = Zero order constant If the zero order kinetic is obeyed, then a plot of Q t vs. t will give a straight line with a slope of K 0 and an intercept at zero. To study the kinetics, data obtained from in vitro studies were plotted as cumulative amount of d vs.. First order kinetics It describes the from the systems in which the rate is concentration dependent. Q t = Q 0 + K 1 t/2.303 Where, Q t = amount of in t Q 0 = initial amount in the solution K 1 = first order constant If the pattern follows first order kinetics, then a plot of log (Q 0- Q t ) versus t will be a straight line with a slope of K 1 /2.303 and an intercept at t=0 of log Q 0. The data obtained are plotted as vs.. Higuchi model It describes the fraction of from a matrix is proportional to square root of. Mt/Mα = K H t 1/2 Where, Mt & Mα = cumulative amounts of rug at t and infinite K H = Higuchi dissolution constant reflection formulation characteristics. If the Higuchi model of (i.e., Fickian diffusion) is obeyed, then a plot of Mt/Mα vs. t 1/2 will be a straight line with a slope of K H. The data obtained were plotted as cumulative vs. square root of. Korsemayer-Peppas model The power law describes that the fractional amount of is exponentially related to the and adequately describes the from slabs, cylinders and spheres. Mt/Mα = Kt n [Mt/Mα] = K + n log t Where, Mt & Mα = cumulative amounts of rug at t and infinite K = constant incorporating structural and geometrical characteristics of CR device n = diffusional exponent indicative of the mechanism of for drug dissolution. To study the kinetics, data obtained from in vitro studies were plotted as vs. log. Table1. Formulation composition of Mefenamic acid Liquisolid Extended tablets Formulation code Drug (mg) PEG-400 (mg) R L f Carrier material (mg) Coating material (mg) AEROSIL-200 F HPMC K100 (mg) Total weight (mg) F F F STARCH F F F F F F AVICEL F PH F ERT* *- Contains Talc & Magnesium stearate (30mg each) without PEG-400 & Aerosil-200 ERT- Normal Extended Release Tablets 83 P a g e
5 Table 2. Solubility results of Mefenamic acid in various solvents at 25 0 C SL.No Solvent / vehicle Solubility (mg/ml) 1 Water Ethanol Propylene glycol Glycerin Buffer S.L.S (10%) Tween Polyethylene glycol Table 3. Micromeritic parameters for mefenamic acid liquisolid powders Sl.No Bulk density Tapped density Angle of Repose (θ)* Carr s index (%)* Hausner s Ratio* Pure drug F ± ± ±0.01 F ± ± ±0.01 F ±o ± ±0.02 F ± ± ±0.01 F ± ± ±0.03 F ± ± ±0.01 F ± ± ±0.02 F ± ± ±0.01 F ± ± ±0.01 F ± ± ±0.01 F ± ± ±0.03 F ± ± ±0.01 ERT ± ± ±0.02 *Mean n=3 Table 4. Post compression parameters for Mefenamic acid Liquisolid tablets Tablet dimensions* Weight Hardness* Friability* SL.No Thickness Diameter variation* (mg) (Kg/Cm 2 ) Fines (%) (mm) (mm) F1 6.16± ± ± ± ±0.3 F2 6.37± ± ± ± ±0.5 F3 6.55± ± ± ± ±0.6 F4 6.61± ± ± ± ±0.1 F5 6.82± ± ± ± ±0.5 F6 7.00± ± ± ± ±0.4 F7 6.12± ± ± ± ±0.1 F8 6.17± ± ± ± ±0.7 F9 6.40± ± ± ± ±0.3 F ± ± ± ± ±0.2 F ± ± ± ± ±0.5 F ± ± ± ± ±0.2 ERT 5.85± ± ± ± ±0.4 *Mean n=3 Content uniformity* (%) Table 5. In-vitro data for Mefenamic acid Extended Liquisolid tablets (hrs) Dissolution medium F1 F2 F3 F4 F5 F6 F7 F8 F9 F10 F11 F12 ERT o.o1 N HCl ph Phosphate P a g e
6 5 buffer ph phosphate buffer Table 6. In-vitro kinetics data for formulation F1 % , Table 7. In-vitro kinetics data for formulation F Table 8. In-vitro kinetics data for formulation F P a g e
7 Table 9. In-vitro kinetics data for formulation F Table 10. In-vitro kinetics data for formulation F Table-11. In-vitro kinetics data for formulation F Table 12. In-vitro kinetics data for formulation F P a g e
8 Table 13. In-vitro kinetics data for formulation F Table 14. In-vitro kinetics data for formulation F Table 15. In-vitro kinetics data for formulation F P a g e
9 Table 16. In-vitro kinetics data for formulation F Table 17. In-vitro kinetics data for formulation F Table 18. In-vitro kinetics data for ERT formulation Table 19. Parameters and determination coefficients of profile from Mefenamic acid extended liquisolid compacts (F1-F12) and extended tablet (ERT) Formulation Correlation Coefficient values (R 2 ) Diffusion Exponent value (n) code Zero First Higuchi Korsemayer-peppas order order F F P a g e
10 F F F F F F F F F F ERT Fig 1. Calibration curve for mefenamic acid at 285nm Fig 2. FT-IR Spectra of Mefenamic acid (pure drug) 89 P a g e
11 Fig 3. FT-IR Spectra of Mefenamic acid + Avicel PH Aerosil HPMC K100M Pradeep Kumar CH. et al. / IJPDT / 3 (2), 2013, Fig 4. FT-IR Spectra of Mefenamic acid + Starch + Aerosil HPMC K100M 90 P a g e
12 Fig 5. FT-IR Spectra of Physical mixture (Mefenamic acid + Avicel PH Starch + Aerosil HPMCK100M + Poly ethylene glycol-400) Fig 6. In-vitro kinetics data (Zero order plots) for formulation F1, F2, F3 91 P a g e
13 Fig 7. In-vitro kinetics data (Zero order plots) for formulation F4, F5, F6 Fig 8. In-vitro kinetics data (Zero order plots) for formulation F7, F8, F9 Fig 9. In-vitro kinetics data (Zero order plots) for formulation F10, F11, F12 Fig 10. In-vitro kinetics data (First order plots) for formulation F1, F2, F3 Fig 11. In-vitro kinetics data (First order plots) for formulation F4, F5, F6 Fig 12. In-vitro kinetics data (First order plots) for formulation F7, F8, F9 92 P a g e
14 Fig 13. In-vitro kinetics data (First order plots) for formulation F10, F11, F12 Fig 14. In-vitro kinetics data (Higuchi plots) for formulation F1, F2, F3 Fig 15. In-vitro kinetics data (Higuchi plots) for formulation F4, F5, F6 Fig 16. In-vitro kinetics data (Higuchi plots) for formulation F7, F8, F9 Fig 17. In-vitro kinetics data (Higuchi plots) for formulation F10, F11, F12 Fig 18. In-vitro kinetics data (Korsemayer- Peppas plots) for formulation F1, F2, F3 93 P a g e
15 Fig 19. In-vitro kinetics data (Korsemayer- Peppas plots) for formulation F4, F5, F6 Fig 20. In-vitro kinetics data (Korsemayer- Peppas plots) for formulation F7, F8, F9 Fig 21. In-vitro kinetics data (Korsemayer- Peppas plots) for formulation F10, F11, F12 Fig 22. Structure of mefenamic acid showing the group responsible for the COX inhibiting activity RESULTS Application of new mathematical model for design of liquisolid systems Mefenamic acid was selected as model drug for this study as a suitable candidate for extended. Liquisolid hypothesis of Spireas et al., states that drug candidate dissolved in liquid nonvolatile vehicle and incorporated into carrier material having porous structure and closely matted fibers in its interior, phenomenon of both adsorption and absorption occurs. This concludes that drug in the form of liquid medication is absorbed initially in the interior of particles of carrier and after saturation of this process it gets adsorbed into internal and external surfaces of carrier. Coating materials such as Aerosil 200 which have high adsorptivity and grater surface area lead the liquisolid systems desirable flow properties [15]. Mathematical model equation for Avicel PH 102 and Aerosil 200 in poly ethylene glycol can be given according to values of Phi (Φ) as given by Spireas et.al. L f = (1/R) Based on this equation, Lf is calculated by using different R values. DISCUSSION Fig-2 demonstrates the FT-IR spectra of pure drug (Mefenamic acid) which shows characteristic peaks at , , , and cm -1 represents C-H bending (Aromatic), O-H bending, C-O stretching, C=C stretching (Aromatic), N-H bending along with C-N stretching respectively. Among which C-H bending (Aromatic), O-H bending, C-O stretching N-H bending along with C-N stretching are responsible peaks for 94 P a g e
16 the formation of acidic group (COOH) which was attached to an aromatic ring of Mefenamic acid. From the MOA of NSAID s (Anthranilates/Fenamates group) it was observed that the acidic group (-COOH) attached to an aromatic ring was responsible for the COX inhibiting activity of Mefenamic acid. Hence when fig-2 (pure drug-mefenamic acid) was compared with fig-3, 4 and 5 (drug with mixture of excipients) we can conclude that there is no characteristic change in the above peaks represents there is no any incompatibilities with the excipients utilized in the formulation of liquisolid compacts, leads FT-IR results were confirming there were no any chemical interactions between the pure drug and physical mixtures. Solubility of mefenamic acid in water, phosphate buffer 7.4, propylene glycol, PEG-400, Glycerin, SLS and Tween-80 was given in table-2. As shown in the table its solubility was found to be very poor in water (0.208mg/ml). In propylene glycol, the solubility of mefenamic acid was found to be 0.218mg/ml, which is slightly greater than that of water. This slight increase is probably through hydrogen bonding. It was found that the solubility of mefenamic acid was very high in PEG-400 (11.50mg/ml) compared with other nonvolatile solvents. This increase in solubility is due to the large non polar part and several hydroxyl groups in PEG were responsible for the enhanced solubility. Thus, among the solvents tested, PEG-400 could be a better choice as a non-volatile solvent. From the micromeritic properties it was observed that mefenamic acid drug alone due to its amorphous nature shows poor flow properties when compared to its physical mixture which shows good flow properties and passable. From the results of post-formulation parameters it was concluded that there should be certain amount of strength or hardness and resistance to friability for the tablet, so that tablet should not break during handling. However, it has also effect on drug dissolution. Average hardness of liquisolid tablet ranges from 5.7±0.19 to 7.3±0.34 kg/cm 2. Compactness of tablet may be due to hydrogen bonding between Avicel PH 102 molecules. As poly ethylene glycol is an alcoholic compound, it might show hydrogen bonding due to presence of hydroxyl groups and may contribute to compactness of compacts. Friability studies of liquisolid compacts are in the range of % to 0.210%. This indicates that acceptable resistance is shown by liquisolid compacts to withstand handling. In preparation of liquisolid compacts, liquid medications containing drug were adsorbed on the surface of carrier materials. When this system is exposed to the dissolution medium, drug located onto the surface of compacts dissolves fast and diffuses into dissolution medium. This can be assumed to be the cause of the burst effect observed. The concentration in liquid medication is an important aspect as it affects. As it was proved previously, increase in drug concentration in liquid medication, lower rate would observe. It was due to fact that at higher drug concentration, drug tends to precipitate within silica (Aerosil 200) pores. At higher amount of Aerosil 200 (Batch F12), was found to be retarded as compared to other batches. Increase in concentration of HPMC K100M might be responsible to get extended effect. This is reflected in batches F5, F6, and F11, F12. However, normal extended tablets showed faster as compared to liquisolid extended formulations. Liquisolid compacts containing Avicel PH 102 retards compared to compacts containing starch as carrier due to high wettability nature of Avicel. Although model independent methods are simple and easy to apply, they lack scientific justification. Hence different model dependent approaches (Zero order, First order, Higuchi, Korsemayer- Peppas plots) were performed for dissolution profile comparison of all liquisolid compacts. The results of these models indicate all liquisolid compacts follow Peppas model as best fit model. This is due to previously proved fact depending on R 2 value obtained from model fitting. From the results batches F6 and F12 showed more retarding effect. It is thus found that T 50 % value increases as concentration of HPMC K100M increases. Korsemayer - Peppas exponent (n) values of all liquisolid compacts are greater than 0.45 indicating non - Fickian diffusion. CONCLUSION From the results it was concluded that, percent was decreased with increase in the concentrations of HPMCK100M. The 12 hour profile may improve patient compliance with the usage of carrier and coating materials along with drug retarding polymer, such that the reduces in the gastric ph and increases when reaches to the intestinal ph which leads to decreased gastric cavity disorders and also the total amount was completely dissolved in to PEG which was further completely available to the intestinal medium after passage through GIT which was not observed in nonliquisolid extended tablets, because the drug in conventional dosage form was not in completely dissolved form hence causes gastric irritation. Based on the in-vitro studies, the data were fitted into different kinetic models shows zero order pattern followed by non-fickian transport mechanism. Drug profiles on model fitting follow Peppas model as best fit model which indicates drug diffusion in hydrated matrix and polymer relaxation. Among the models used for dissolution profile comparison, it was concluded that model independent methods were found to be very simple, but discrimination between dissolution profiles can be found using model dependent approach. 95 P a g e
17 REFERENCES 1. Thakur N, Khokra SL, Sharma D, Thakur NS, Purohit R and Arya V. A review on pharmaceutical applications of liquisolid technique. Amer J Pharmatech Res, 1(3), 2011, Baby DA, Saroj S and Sabitha M. Mechanism of solubility of liquisolid formulation in non volatile solvent: A Review. Int J Pharm Pharm Sci, 4(3), 2012, Meer TA, Sav A. Solubility Enhancement of Carvidilol using Liquisolid Compact Technique. Journal of Applied Pharmacy, 1(4), 2012, Gubbi S, Jarag R. Liquisolid Technique for Enhancement of Dissolution Properties of Bromhexine Hydrochloride. Research Journal of Pharmacy and Technology, 2(2), 2009, Akinlade B, Elkordy AA. Liquisolid Systems to Improve the Dissolution of Furosemide. Scientia Pharmaceutica, 78, 2010, Javadzadeh Y, Ali N. Liquisolid Technique for Dissolution Rate Enhancement of a High Dose Water-Insoluble Drug (Carbamazepine). International Journal of Pharmaceutics, 341, 2007, Karmarkar AB, Gonjari ID. Dissolution Rate Enhancement of Fenifibrate using Liquisolid Tablet Technique. Latin American Journal of Pharmacy, 28(2), 2009, Yadav VB, Yadav AV. Improvement of Solubility and Dissolution of Indomethacin by Liquisolid and Compaction Granulation Technique. Journal of Pharmacy Science & Research, 1(2), 2009, Yadav AV, Shete AS. Formulation and Evaluation of Orodispersible Liquisolid Compacts of Aceclofenac. Indian Journal of Pharmacy Education and Research, 44(3), 2010, Nagabandi V, Tadikonda R. Formulation Development and Evaluation of Liquisolid Systems to Improve the Dissolution Rate of Ketoprofen. International Journal of Biomedical Research, 2(10), 2011, Nokhodchi A, Aliakbar R. Liquisolid Compacts: The Effect of Co solvent and HPMC on Theophylline Release. Journal of Colloid Surface Study, 79, 2010, Javadzadeh Y, Musaalrezaei. Liquisolid Technique as a New Approach to Sustain Propranolol Hydrochloride Release from Tablet Matrices. International Journal of Pharmaceutics, 362, 2008, Kasture SV, Gondkar SB. Enhancement of Dissolution Rate of Lansoprazole Using Liquisolid Tablet Technique. International Journal of Pharmaceutical Research, 3(2), 2011, Boghra R, Patel A. Formulation and Evaluation of Irbesartan Liquisolid Tablets. International Journal of Pharma Science Review and Research, 9(2), 2011, Ganesh NS, Deecaraman. Formulation and Evaluation of Sustained Release Lornoxicam by Liquisolid Technique. International Journal of Pharmacy Science Review and Research, 11(1), 2011, Burra S, Kudikala S. Formulation and Evaluation of Simvastatin Liquisolid Tablets. Der Pharmacia letter, 3(2), 2011, Gonjari ID, Karmakar AB. Evaluation of In vitro Dissolution Profile Comparison Methods of Sustained Release Tramadol Hydrochloride Liquisolid Compact Formulations with Marketed Sustained Release Tablets. Drug Discoveries & Therapeutics, 2010, 4(1), Karmarkar AB. Effect of Ceolus KG-802 on the Dissolution Rate of Fenofibrate Liquisolid Tablets: Preformulation and Formulation Development Studies. Drug Discoveries & Therapeutics, 4(6), 2010, Spiras S, Bolton SM. Liquisolid systems and methods for preparing same, United States patent 5,968,550, Grover R, Spireas S, Wang T. Effect of powder substrate on the dissolution properties of Methchrothiazide liquisolid compacts. Drug Dev Ind Pharm, 25, 1999, Furer R, Geiger M. A simple method of determining the aqueous solubility of organic substances. J Pharm Sci, 8(4), 1976, Spiras S. Liquisolid systems and methods for preparing same, United States patent 6, 423, 339 BI, Spiras S, Bolton SM. Liquisolid systems and methods for preparing same, United States patent 6,096,337, Spiro S, Srinivas S. Enhancement of Prednisolone dissolution properties using liquisolid compacts. Int J Pharm, 166, 1998, Li XS, Wang JX, Shen ZG et al., Preparation of uniform Prednisolone micro crystals by a controlled micro precipitation method. Int J Pharm, 342, 2007, Liao CC, Jarowski CI. Dissolution rates of corticoid solutions dispersed on silicas. J Pharm Sci, 73, 1984, Subhramanyam CVS. Textbook of Physical Pharmaceutics, 2 nd ed, Vallabh Prakashan, New Delhi, 2001, Martin. Physical Pharmacy. 2, 2003, Brahmankar DM, Jaishwal SB. Biopharmaceutics and Pharmacokinetics a Trease, Vallabh Prakashan, Delhi. 1, 1995, P a g e
INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH AND BIO-SCIENCE
INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH AND BIO-SCIENCE ENHANCEMENT OF SOLUBILITY AND DISSOLUTION RATE OF RIFAMPICIN THROUGH LIQUID SOLID TECHNOLOGY PATEL KANU J., PATEL Y.K. Sharda School of
More informationFormulation and in vitro evaluation of candesartan liquid solid compacts to enhance drug solubility
IJPAR Vol.5 Issue 1 Jan- Mar -2016 Journal Home page: ISSN:2320-2831 Research article Open Access Formulation and in vitro evaluation of candesartan liquid solid compacts to enhance drug solubility Sai
More informationResearch Article FORMULATION AND EVALUATION OF TELMISARTAN LIQUISOLID COMPACT TABLETS
ISSN 2395-3411 Available online at www.ijpacr.com 155 Research Article FORMULATION AND EVALUATION OF TELMISARTAN LIQUISOLID COMPACT TABLETS Dhananjay Ahir*, Rajeshree Panigrahi, Prasanta Kumar Choudhury
More informationSOLUBILITY ENHANCEMENT OF RIFAMPICIN BY USING LIQUISOLID TECHNIQUE
Research Article Rajesh Asija,, 2013; Volume 2(2): 203-218 ISSN: 2277-8713 SOLUBILITY ENHANCEMENT OF RIFAMPICIN BY USING LIQUISOLID TECHNIQUE ASIJA RAJESH, PATEL PINKESH, ASIJA SANGEETA, PATEL CHIRAG J,
More informationENHANCEMENT OF SOLUBILITY AND DISSOLUTION PROPERTIES OF LOVASTATIN BY LIQUISOLID TECHNIQUE
INTERNATIONAL JOURNAL OF RESEARCH IN PHARMACY AND CHEMISTRY Available online at www.ijrpc.com Research Article ENHANCEMENT OF SOLUBILITY AND DISSOLUTION PROPERTIES OF LOVASTATIN BY LIQUISOLID TECHNIQUE
More informationScholars Research Library
Available online at www.scholarsresearchlibrary.com Scholars Research Library Der Pharmacia Lettre, 2010, 2(5): 412-427 (http://scholarsresearchlibrary.com/archive.html) ISSN 0975-5071 USA CODEN: DPLEB4
More informationFORMULATION AND EVALUATION OF REPAGLINIDE FAST DISSOLVING TABLETS
INTERNATIONAL JOURNAL OF RESEARCH IN PHARMACY AND CHEMISTRY Available online at www.ijrpc.com Research Article FORMULATION AND EVALUATION OF REPAGLINIDE FAST DISSOLVING TABLETS Chirravuri S Phani Kumar
More informationIMPROVEMENT OF DISSOLUTION PROFILE OF LORNOXICAM BY SOLID DISPERSION USING SPRAY DRYING TECHNIQUE
66 P a g e International Standard Serial Number (ISSN): 2319-8141 International Journal of Universal Pharmacy and Bio Sciences 3(5): September-October 2014 INTERNATIONAL JOURNAL OF UNIVERSAL PHARMACY AND
More informationCHAPTER-3 MATERIALS AND METHODS
75 CHAPTER-3 MATERIALS AND METHODS 76 3.1 MATERIALS 3.1.1 Drugs used in the present study Lamivudine Zidovudine Stavudine Drug name Source Alchem laboratories, Mumbai, India 3.1.2 Excipients and chemicals
More informationDISSOLUTION PROFILLING OF NIMESULIDE SOLID DISPERSIONS WITH POLYETHYLENE GLYCOL, TALC AND THEIR COMBINATIONS AS DISPERSION CARRIERS
International Journal of PharmTech Research CODEN (USA): IJPRIF ISSN : 0974-4304 Vol.2, No.1, pp 480-484, Jan-Mar 2010 DISSOLUTION PROFILLING OF NIMESULIDE SOLID DISPERSIONS WITH POLYETHYLENE GLYCOL, TALC
More informationMouth Disintegrating Tablets of Taste-Masked Ondansetron HCl
Asian Journal of Chemistry Vol. 19, No. 5 (2007), 3455-3460 Mouth Disintegrating Tablets of Taste-Masked Ondansetron HCl V.K. CHATAP, D.K. SHARMA*, ANIL MIDDHA, R.D. GUPTA, VIPIN SAINI, MAHENDRA SHIRADKAR
More informationS.Janakidevi et al. Int. Res. J. Pharm. 2014, 5 (7) INTERNATIONAL RESEARCH JOURNAL OF PHARMACY
INTERNATIONAL RESEARCH JOURNAL OF PHARMACY www.irjponline.com ISSN 2230 8407 Research Article DESIGN AND OPTIMIZATION OF CEFIXIME TRIHYDRATE SUSTAINED RELEASE MATRIX TABLETS USING DIFFERENT POLYMERS S.Janakidevi*,
More informationFORMULATION AND EVALUATION OF FAST DISSOLVING TABLETS OF GLICLAZIDE
ISSN 976 44X Research Article FORMULATION AND EVALUATION OF FAST DISSOLVING TABLETS OF GLICLAZIDE Ch.T.Lalitha kumari*, Dr.M.Mohan Varma, P.Satish Kumar, N. Jahnavi Shri Vishnu College of Pharmacy, Vishnupur,
More informationLiquisolid Technique for Enhancement of Dissolution Properties of Lornoxicam
Liquisolid Technique for Enhancement of Dissolution Properties of Lornoxicam Shobhit Srivastava, Dipti Srivastava *, Nimisha, Vedant Prajapat Amity Institute of Pharmacy, Amity University Lucknow, Uttar
More informationWorld Journal of Pharmaceutical Research SJIF Impact Factor 5.990
SJIF Impact Factor 5.990 Volume 5, Issue 01, 1015-1047. Research Article ISSN 2277 7105 SOLUBILITY ENHANCEMENT OF SERTRALINE HYDROCHLORIDE-FORMULATION & COMPARATIVE EVALUATION OF LIQUID SOLID COMPACTS
More informationMd.Khairul Alam et al / Journal of Pharmaceutical Science and Technology Vol. 3 (6), 2011,
STUDY OF DISSOLUTION IMPROVEMENT OF VARIOUS POORLY WATER SOLUBLE DRUGS BY SOLID DISPERSION MIXING WITH HPMC 6CPS AND PEG 6 Md. Khairul Alam 1 *, Reza-ul Jalil 2, Nazia Zaman 1, Md. SM Ashraful Islam 3
More informationINTERNATIONAL JOURNAL OF PHARMACEUTICAL AND CHEMICAL SCIENCES
Research Article An In-Vitro Evaluation for the Effect of Β-Cyclodextrin and PVP-K 3 on Drug Release Pattern of Sertraline Hydrochloride Deepa Warrier 1, Aanna Zagade 1, Amir Shaikh 2*, Yogesh Pawar 2
More informationFormulation and evaluation of matrix tablets of Famotidine using hydrophilic polymer
Available online at www.scholarsresearchlibrary.com Scholars Research Library Archives of Applied Science Research, 2010, 2 (3):212-220 (http://scholarsresearchlibrary.com/archive.html) ISSN 0975-508X
More informationResearch Article DESIGN AND EVALUATION OF SUSTAINED RELEASE FORMULATIONS OF THEOPHYLLINE USING NATURAL POLYMERS
International Journal of Research and Development in Pharmacy and Life Sciences Available online at http//www.ijrdpl.com October - November, 2013, Vol. 2, No.6, pp 721-725 ISSN: 2278-0238 Research Article
More information8. FORMULATION OF LANSOPRAZOLE NANOPARTICLES
8. FORMULATION OF LANSOPRAZOLE NANOPARTICLES FORMULATION OF LANSOPRAZOLE NANOPARTICLES Preparation of capsule of modified solubility to protect the drug from degradation To protect the drug from degradation
More informationFormulation and in-vitro Evaluation of Captopril Floating Matrix Tablets Using HPMC 50cps
Formulation and in-vitro Evaluation of Captopril Floating Matrix Tablets Using HPMC 50cps Basawaraj S.Patil*, Sandeep J. Sonawane, Upendra Kulkarni, Hariprasanna R.C. PG Department of Pharmaceutics, R.M.E.S
More informationDesign and In Vitro Characterization of Dexlansoprazole Controlled Release Tablets
ORIGINAL ARTICLE Design and In Vitro Characterization of Dexlansoprazole Controlled Release Tablets Y. Naveen Kumar 1, J. Sreekanth 2, P. Vijay Chander Reddy 3 1 Drugs Control Administration, Hyderabad,
More informationChapter 7 FORMULATION AND CHARACTERIZATION OF PULSINCAP
161 Chapter 7 FORMULATION AND CHARACTERIZATION OF PULSINCAP 162 Chapter 7 FORMULATION AND CHARACTERIZATION OF PULSINCAP S.No. Name of the Sub-Title Page No. 7.1. Optimization of formulations of Pulsincap
More informationCOMPARATIVE EVALUATION OF SOLUBILITY AND DISSOLUTION ENHANCEMENT OF BICALUTAMIDE SOLID BY DISPERSION TECHNIQUE
COMPARATIVE EVALUATION OF SOLUBILITY AND DISSOLUTION ENHANCEMENT OF BICALUTAMIDE SOLID BY DISPERSION TECHNIQUE Katare M. Kumar 1*, Jain A. Pal 2 and Kohli S 3 1. Shri Ram Institute of Technology (Pharmacy),
More informationReceived 25 March, 2010; received in revised form 03 June, 2010; accepted 15 June, 2010
ISSN: 0975-8232 IJPSR (2010), Vol. 1, Issue 7 (Research Article) Received 25 March, 2010; received in revised form 03 June, 2010; accepted 15 June, 2010 IMPROVEMENT OF DISSOLUTION BEHAVIOR OF PARACETAMOL
More informationOPTIMIZATION OF FUROSEMIDE LIQUISOLID TABLETS PREPARATION PROCESS LEADING TO THEIR MASS AND SIZE REDUCTION
Acta Poloniae Pharmaceutica ñ Drug Research, Vol. 73 No. 5 pp. 1325ñ1331, 2016 ISSN 0001-6837 Polish Pharmaceutical Society OPTIMIZATION OF FUROSEMIDE LIQUISOLID TABLETS PREPARATION PROCESS LEADING TO
More informationPreparation And Characterization Of Simvastatin Nanosuspension By Homogenization Method
International Journal of PharmTech Research CODEN (USA): IJPRIF ISSN : 0974-4304 Vol.5, No.1, pp 193-197, Jan-Mar 2013 Preparation And Characterization Of Simvastatin Nanosuspension By Homogenization Method
More informationIN VITRO DISSOLUTION KINETIC STUDY OF THEOPHYLLINE FROM HYDROPHILIC AND HYDROPHOBIC MATRICES
Acta Poloniae Pharmaceutica ñ Drug Research, Vol. 63 No. 1 pp. 63ñ67, 2006 ISSN 0001-6837 Polish Pharmaceutical Society IN VITRO DISSOLUTION KINETIC STUDY OF THEOPHYLLINE FROM HYDROPHILIC AND HYDROPHOBIC
More informationSolubility and Dissolution Rate Determination of Different Antiretroviral Drugs in Different ph Media Using UV Visible Spectrophotometer
ISSN: 973-4945; CODEN ECJHAO E- Chemistry http://www.e-journals.net 28, 5(S2), 1159-1164 Solubility and Dissolution Rate Determination of Different Antiretroviral Drugs in Different ph Media Using UV Visible
More informationImpact of Granulation and Effect of Polymers on Theophylline Release from Matrix Tablets
Impact of Granulation and Effect of Polymers on Theophylline Release from Matrix Tablets Kazi Rashidul Azam, Md. Shaikhul Millat Ibn Razzak, Ferdous Khan, Muhammad Shahidul Islam, Md. Ruknuzzaman Rony
More informationIndian Journal of Research in Pharmacy and Biotechnology
Formulation and evaluation of enteric coated sustained release matrix tablets of Duloxetine hydrochloride A.Bharathi*, P.Rama Chandra rao, V.Aswini priya, N.Anusha Department of Pharmaceutical Sciences,
More informationFormulation and characterization of atorvastatin calcium liquisolid compacts
Formulation and characterization of atorvastatin calcium liquisolid compacts Sanjeev Raghavendra Gubbi *, Ravindra Jarag Department of Pharmaceutics, Bharati Vidyapeeth College of Pharmacy, Near Chitranagari,
More informationAvailable online through ISSN
Research Article Available online through www.ijrap.net ISSN 2229-3566 COMPARISON OF IN VITRO DISSOLUTION PROFILES OF CEFPODOXIME PROXETIL - PEG SOLID DISPERSIONS WITH CEPODOXIME PROXETIL Madgulkar Ashwini
More informationINTERNATIONAL RESEARCH JOURNAL OF PHARMACY
INTERNATIONAL RESEARCH JOURNAL OF PHARMACY www.irjponline.com ISSN 2230 8407 Research Article FORMULATION AND EVALUATION OF SUSTAINED RELEASE TABLET OF DILTIAZEM HYDROCHLORIDE BY MELT GRANULATION TECHNOLOGY
More informationResearch Article. Development of Controlled Release Tablets of Nisoldipine with Improved Pharmaceutical Properties
Available online www.jocpr.com Journal of Chemical and Pharmaceutical Research, 2013, 5(7):112-120 Research Article ISSN : 0975-7384 CODEN(USA) : JCPRC5 Development of Controlled Release Tablets of Nisoldipine
More informationEnhancement of Dissolution Rate of Nimesulide by Liquisolid Compaction Technique
International Journal of PharmTech Research CODEN (USA): IJPRIF ISSN : 0974-4304 Vol.4, No.3, pp 1294-1302, July-Sept 2012 Enhancement of Dissolution Rate of Nimesulide by Liquisolid Compaction Technique
More informationFORMULATION AND OPTIMIZATION OF LIQUISOLID TABLETS OF OLMESARTAN MEDOXOMIL USING 3 2 FACTORIAL DESIGN
IJPSR (2017), Volume 8, Issue 11 (Research Article) Received on 17 March, 2017; received in revised form, 23 May, 2017; accepted, 27 May, 2017; published 01 November, 2017 FORMULATION AND OPTIMIZATION
More informationResearch Article. Dissolution Study of Oxolamine Citrate by UV Spectrophotometric Method in Pharmaceutical Dosage Form
Available online www.jocpr.com Journal of Chemical and Pharmaceutical Research, 2016, 8(7):108-112 Research Article ISSN : 0975-7384 CODEN(USA) : JCPRC5 Dissolution Study of Oxolamine Citrate by UV Spectrophotometric
More informationThe Influence of Hydro-Alcoholic Media on Hypromellose Matrix Systems
METHOCEL Application Data Premium Cellulose Ethers The Influence of Hydro-Alcoholic Media on Hypromellose Matrix Systems OBJECTIVES The hydrophilic matrices (HM) continue to be a popular and widely used
More informationFormulation and in-vitro evaluation of sustained release matrix tablets of gliclazide
Research Article S.Shanmugamet al. /BioMedRx 2013,1(4), Available online through http://jprsolutions.info Formulation and in-vitro evaluation of sustained release matrix tablets of gliclazide S.Shanmugam,
More informationFormulation development and In-Vitro evaluation of floating tablets of Cefixime
48 Formulation development and In-Vitro evaluation of floating tablets of Cefixime B. Venkateswara Reddy Department of Pharmaceutics, St. Pauls College of Pharmacy, Hayathnagar, R.R. Dist, India basu.pharmacist@gmail.com
More informationINTERNATIONAL JOURNAL OF INSTITUTIONAL PHARMACY AND LIFE SCIENCES
International Journal of Institutional Pharmacy and Life Sciences 6(2): March-April 2016 INTERNATIONAL JOURNAL OF INSTITUTIONAL PHARMACY AND LIFE SCIENCES Pharmaceutical Sciences Research Article!!! Received:
More informationDissolution Method Development and Validation of Paracetamol Aceclofenac Tablets
Research Article Dissolution Method Development and Validation of Paracetamol Aceclofenac Tablets Heena Farheen, T. Mamatha*, Zareena Yasmeen and Sharmila Sutradhar Department of Quality Assurance, Sultan-Ul-Uloom
More informationUV Spectrophotometric Method Development and Validation of Ezetimibe and Simvastatin in Bulk and Pharmaceutical Dosage Form
ISSN 2395-3411 Available online at www.ijpacr.com 581 Research Article UV Spectrophotometric Method Development and Validation of Ezetimibe and Simvastatin in Bulk and Pharmaceutical Dosage Form Namratha
More informationMohammad.Zuber. et al. / International Journal of Biopharmaceutics. 2012; 3(1): International Journal of Biopharmaceutics
44 e- ISSN 0976-1047 Print ISSN 2229-7499 International Journal of Biopharmaceutics Journal homepage: www.ijbonline.com IJB THE EFFECT OF VARIOUS SURFACTANTS ON RELEASE BEHAVIOR OF LIDOCAINE HCL FROM ETHYLCELLULOSE
More informationInternational Journal of Chemistry and Pharmaceutical Sciences. International Journal of Chemistry and Pharmaceutical Sciences
D. Nirmala Kumari et al, IJCPS, 2015, 3(5): 1678 1683 ISSN: 2321-3132 International Journal of Chemistry and Pharmaceutical Sciences Journal Home Page: www.pharmaresearchlibrary.com/ijcps Research Article
More informationPractical Pharmaceutical Technology I USP Dissolution Method for PARACETAMOL 500 mg Tablets Section No. 6 Group D
University of Jordan Faculty of Pharmacy Practical Pharmaceutical Technology I USP Dissolution Method for PARACETAMOL 500 mg Tablets Section No. 6 Group D USP Dissolution Method for PARACETAMOL 500 mg
More informationINTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH AND BIO-SCIENCE
INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH AND BIO-SCIENCE FORMULATION AND EVALUATION OF SUSTAINED RELEASE PELLETS OF BOSENTAN HCl SIDDHI V. PATEL 1,2, DR. MUKESH S. PATEL 2 1. Research scholar,
More informationDicyclomine-loaded Eudragit -based Microsponge with Potential for Colonic Delivery: Preparation and Characterization
Tropical Journal of Pharmaceutical esearch, February 2010; 9 (1): 67-72 Pharmacotherapy Group, Faculty of Pharmacy, University of Benin, Benin City, 300001 Nigeria. All rights reserved. esearch Article
More informationAREA UNDER CURVE AND SECOND ORDER DERIVATIVE SPECTROSCOPY OF METAXALONE IN BULK DRUG AND TABLET FORMULATION
Int. J. Chem. Sci.: 8(2), 2010, 823-827 AREA UNDER CURVE AND SECND RDER DERIVATIVE SPECTRSCPY F METAXALNE IN BULK DRUG AND TABLET FRMULATIN J. PRIYADHARISINI, G. P. GIGI, V. NIRAIMATHI and A. JERAD SURESH
More informationJournal of Chemical and Pharmaceutical Research, 2012, 4(3): Research Article
Available online www.jocpr.com Journal of Chemical and Pharmaceutical Research, 2012, 4(3):1573-1579 Research Article ISSN : 0975-7384 CODEN(USA) : JCPRC5 In vitro release kinetic study of ambroxol hydrochloride
More informationIn Vivo-In Vitro Evaluation of Solid Dispersion Containing Ibuprofen
American Journal of Advanced Drug Delivery www.ajadd.co.uk In Vivo-In Vitro Evaluation of Solid Dispersion Containing Ibuprofen Original Article Sachin K. Gawai*, Subhash V. Deshmane, R. N. Purohit, Kailash
More informationKing Saud University College of Pharmacy Department of Pharmaceutics. Biopharmaceutics PHT 414. Laboratory Assignments 2010 G 1431 H
King Saud University College of Pharmacy Department of Pharmaceutics Biopharmaceutics PHT 414 Laboratory Assignments 20 G 1431 H Department of Pharmaceutics Biopharmaceutics PHT -414 Laboratory Assignments
More informationInternational Journal of Innovative Pharmaceutical Sciences and Research
International Journal of Innovative Pharmaceutical Sciences and Research www.ijipsr.com FORMULATION AND EVALUATION OF MONTLUKAST SODIUM EXTENDED RELEASE MATRIX TABLET 1 G.Rajini*, 2 Dr N. Srinivas Malla
More informationResearch Article. Improvement of dissolution rate of diacerein using liquisolid technique
Available online www.jocpr.com Journal of Chemical and Pharmaceutical Research, 2016, 8(7):209-219 Research Article ISSN : 0975-7384 CODEN(USA) : JCPRC5 Improvement of dissolution rate of diacerein using
More informationFormulation and Evaluation of Immediate Release Tablets of Nevirapine Solid Dispersions
ARC Journal of Pharmaceutical Sciences (AJPS) Volume 4, Issue 3, 2018, PP 13-20 ISSN No.: 2455-1538 DOI: http://dx.doi.org/10.20431/2455-1538.0404003 www.arcjournals.org Formulation and Evaluation of Immediate
More informationUse of Roller Compaction in the Preparation of Verapamil Hydrochloride Extended Release Matrix Tablets Containing Hydrophilic Polymers
METHOCEL Application Data Premium Cellulose Ethers Use of Roller Compaction in the Preparation of Verapamil Hydrochloride Extended Release Matrix Tablets Containing Hydrophilic Polymers ABSTRACT SUMMARY
More informationScholars Research Library. Innovation on Development and Evaluation of Gastric Oral Floating Capsules Containing Captopril
Available online at www.scholarsresearchlibrary.com Der Pharmacia Lettre, 2011, 3(3): 103-109 (http://scholarsresearchlibrary.com/archive.html) ISSN 0975-5071 USA CODEN: DPLEB4 Innovation on Development
More informationAsian Journal of Biomedical and Pharmaceutical Sciences 1 (3) 2011, 13-19
Asian Journal of Biomedical and Pharmaceutical Sciences 1 (3) 2011, 13-19 RESEARCH ARTICLE ISSN 2249-622X Formulation and Evaluation of Extended Release Solid Dispersions Conatining Simvastatin Prasad
More informationINTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH AND BIO-SCIENCE
INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH AND BIO-SCIENCE FORMULATION AND IN-VITRO EVALUATION OF TOLBUTAMIDE MICROCAPSULES NAGESWARA RAO. G, RAMA KRISHNA. A Department of Pharmaceutical Chemistry,
More informationInternational Journal of Pharma and Bio Sciences
Research Article Bioinformatics International Journal of Pharma and Bio Sciences ISSN 0975-6299 MODEL DEPENDANT AND STATISTICAL APPROACHES TO STUDY RELEASE KINETICS OF MELOXICAM RELEASE MATRIX TABLETS
More informationDissolution enhancement of aceclofenac tablet by solid dispersion technique
Dissolution enhancement of aceclofenac tablet by solid dispersion technique Kiroj Rajbanshi 1*, Rajiv Bajracharya 2, Ashwinee Shrestha 2, Panna Thapa 1, 2 Department of Pharmacy, School of Science, Kathmandu
More informationInternational Journal of Medicine and Health Profession Research
Research Article ISSN: 2394 7403 International Journal of Medicine and Health Profession Research Journal home page: www.ijmhpr.com FORMULATION AND EVALUATION OF GASTRORETENTIVE FLOATING SUSTAINED RELEASED
More informationJournal home page:
Page6460 Indo American Journal of Pharmaceutical Research, 2013 ISSN NO: 2231-6876 Journal home page: http:///index.php/en/ INDO AMERICAN JOURNAL OF PHARMACEUTICAL RESEARCH PHASE SOLUBILITY STUDY ON MUSCLE
More informationINTERNATIONAL JOURNAL OF INSTITUTIONAL PHARMACY AND LIFE SCIENCES
International Journal of Institutional Pharmacy and Life Sciences 5(5): September-October 2015 INTERNATIONAL JOURNAL OF INSTITUTIONAL PHARMACY AND LIFE SCIENCES Pharmaceutical Sciences Research Article!!!
More informationEnhancing the solubility of Candesartan cilexetil-inclusion Complexation using
International Journal of Drug Delivery 6 (2014) 179-185 http://www.arjournals.org/index.php/ijdd/index Original Research Article ISSN: 0975-0215 Enhancing the solubility of Candesartan cilexetil-inclusion
More informationCHAPTER - 5 DEVELOPMENT AND EVALUATION OF ALFUZOSIN ER TABLETS
55 CHAPTER - 5 DEVELOPMENT AND EVALUATION OF ALFUZOSIN ER TABLETS 5.1 MATERIALS AND EQUIPMENTS Table 5.1: List of materials used in research work Name of the Material Manufacturer Alfuzosin Hydrochloride
More informationResearch Article DEVELOPMENT AND CHARACTERIZATION OF ACECLOFENAC ENTERIC COATED TABLETS
International Journal of Research and Development in Pharmacy and Life Sciences Available online at http//www.ijrdpl.com October - November, 2015, Vol. 4, No.6, pp 1861-1866 ISSN (P): 2393-932X, ISSN (E):
More informationInternational Journal of Research in Pharmaceutical and Nano Sciences Journal homepage:
Research Article CODEN: IJRPJK ISSN: 2319 9563 International Journal of Research in Pharmaceutical and Nano Sciences Journal homepage: www.ijrpns.com FORMULATION, OPTIMIZATION AND INVITRO EVALUATION OF
More informationFormulation of Low Dose Medicines - Theory and Practice
Hashim Ahmed, Ph.D. and Navnit Shah, Ph.D. Pharmaceutical and Analytical R&D, Hoffmann-La Roche Inc., Nutley NJ Formulation of Low Dose Medicines - Theory and Practice Progress in pharmaceutical research
More informationDevelopment of Discriminating Method for Dissolution of Aceclofenac Marketed Formulations
dx.doi.org/10.14227/dt150208p31 Development of Discriminating Method for Dissolution of Aceclofenac Marketed Formulations e-mail: tejalsoni_2973@yahoo.com Tejal Soni 1,4, Chirag Nagda 2,Tejal Gandhi 2,
More informationFORMULATION, DEVELOPMENT AND CHARACTERIZATION OF ORAL DISINTEGRAING TABLET OF CIMITIDINE HCL
wjpmr, 2018,4(12), 233-237 SJIF Impact Factor: 4.639 Marabathuni et al. Research Article WORLD JOURNAL OF PHARMACEUTICAL AND MEDICAL RESEARCH ISSN 2455-3301 www.wjpmr.com WJPMR FORMULATION, DEVELOPMENT
More informationPowder. Aulton Chapter 8-10,14,24. Powders
Powder Aulton Chapter 8-10,14,24 Powders Powders are important in the development of pharmaceutical products since many formulations either is powders or contain powders 1 Pharmaceutical powders Different
More informationAugmentation of Dissolution Profile of Poorly Soluble Paliperidone by employing Liquisolid Technology
International Journal of PharmTech Research CODEN (USA): IJPRIF ISSN : 0974-4304 Vol.6, No.2, pp 710-719, April-June 2014 Augmentation of Dissolution Profile of Poorly Soluble Paliperidone by employing
More informationEffect of Alkaline Excipients on The Release Profile of Gliclazide Extended Release Tablets
Effect of Alkaline Excipients on The Release Profile of Gliclazide Extended Release Tablets Monika Srivastav 1, B Prabhakar 1, Ashok Omray 2 1 School of Pharmacy & Technology Management, NMIMS University,
More informationResearch Article Formulation of Indomethacin Colon Targeted Delivery Systems Using Polysaccharides as Carriers by Applying Liquisolid Technique
BioMed Research International, Article ID 74362, 17 pages http://dx.doi.org/1.1155/14/74362 Research Article Formulation of Indomethacin Colon Targeted Delivery Systems Using Polysaccharides as Carriers
More informationFORMULATION AND EVALUATION OF PIROXICAM LIQUISOLID COMPACTS
Academic Sciences International Journal of Pharmacy and Pharmaceutical Sciences ISSN- 0975-1491 Vol 5, Issue 1, 2013 FORMULATION AND EVALUATION OF PIROXICAM LIQUISOLID COMPACTS Research Article AHMED S.
More informationIDENTIFICATION TESTS FOR DURACOR TABLETS
PAGE 1 OF 8 IDENTIFICATION TESTS FOR DURACOR TABLETS PAGE 2 OF 8 PROTOCOL APPROVALS Norvin Pharma Inc. Signature and Date Author Analytical Laboratory Approver Analytical Laboratory Group Leader Approver
More informationFormulation Design And Invitro Evaluation Of Sustained Release Matrix Tablets Of Losartan Potassium Using HPMC Polymers
International Journal of PharmTech Research CODEN (USA): IJPRIF ISSN : 0974-4304 Vol.5, No.3, pp 1332-1344, July-Sept 2013 Formulation Design And Invitro Evaluation Of Sustained Release Matrix Tablets
More informationValidated spectrophotometric determination of Fenofibrate in formulation
Available online at www.pelagiaresearchlibrary.com Der Pharmacia Sinica, 2010, 1 (1): 173-178 Validated spectrophotometric determination of Fenofibrate in formulation Krishna R. Gupta*, Sonali S. Askarkar,
More informationFormulation and evaluation of sustained release matrix tablets of nifedipine
IJPAR Vol.4 Issue 3 Jul-Sep-2015 Journal Home page: ISSN: 2320-2831 Research article Open Access Formulation and evaluation of sustained release matrix tablets of nifedipine Eswar kumar.a 1*, A.Vaishnavi,
More informationPharmaceutics and Pharmaceutical Technology
Pharmaceutics and Pharmaceutical Technology Pharmaceutics and Pharmaceutical Technology Laboratories Lab Name Location Person in Charge Programs Served Courses Served Pharmaceutics A M12-127 Pharmaceutics
More informationKeywords: Sustained release matrices, Eudragit, particle size, Aerosil 200, compaction force
Iranian Journal of Basic Medical Sciences Vol. 1, No. 3, Autumn 7, 197-5 Received: Jun 9, 7; Accepted: Oct 9, 7 Effect of Particle Size, Compaction Force and Presence of Aerosil on the Properties of Matrices
More informationFORMULATION OF SUSTAIN RELEASE SOLID DISPERSIONS OF VERAPAMIL HYDROCHLORIDE USING ETHYL CELLULOSE AND EUDRAGIT RSPO
International Journal of Pharmacy and Pharmaceutical Sciences ISSN- 975-1491 Vol 3, Issue 1, 211 Research Article FORMULATION OF SUSTAIN RELEASE SOLID DISPERSIONS OF VERAPAMIL HYDROCHLORIDE USING ETHYL
More informationAtenolol Press Coated (HE) Tablet
CHAPTER 6: FORMULATION AND EVALUATION OF ATENOLOL PULSATILE PRESS COATED TABLETS USING RUPTURABLE AND ERODIBLE POLYMERS 6.1. INTRODUCTION AND AIM OF THE STUDY In order to achieve the chronopharmaceutical
More informationInfluence of different grades and concentrations of hydroxypropyl methyl cellulose on the release of metformin hydrochloride
World Journal of Pharmaceutical Sciences ISSN (Print): 2321-3310; ISSN (Online): 2321-3086 Published by Atom and Cell Publishers All Rights Reserved Available online at: http://www.wjpsonline.org/ Original
More informationImpact factor: /ICV: PROCESS VALIDATION OF PARACETAMOL SUSPENSION Sisal Shah*, Dinesh G. Desai, A. K.
Impact factor:.3397/icv: 4. 299 Pharma Science Monitor 6(2), Apr-Jun 25 PHARMA SCIENCE MONITOR AN INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES Journal home page: http://www.pharmasm.com PROCESS VALIDATION
More informationInternational Journal of Innovative Pharmaceutical Sciences and Research
International Journal of Innovative Pharmaceutical Sciences and Research www.ijipsr.com FORMULATION AND EVALUATION OF FAST DISSOLVING TABLETS OF IBUPROFEN 1 K.Vinay Kumar*, 1 V. Swetha Kruthika, 1 C.V.S
More informationOndansetron hydrochloride (OSH) is an effective
dx.doi.org/10.14227/dt200413p34 In Vitro Dissolution Enhancement of Ondansetron by Solid Dispersion in Superdisintegrants e-mail: rkpharma26@yahoo.co.in Rajnikant M. Suthar 1, *, Narendra P. Chotai 1,
More informationDesign and Technology of Liquisolid Compacts
. Journal of Applied Pharmaceutical Science Vol. 3 (8 Suppl 1), pp. S111-S119, August, 2013 Available online at http://www.japsonline.com DOI: 10.7324/JAPS.2013.38.S17 ISSN 2231-3354 Design and Technology
More informationCHAPTER - 3 ANALYTICAL PROFILE. 3.1 Estimation of Drug in Pharmaceutical Formulation Estimation of Drugs
CHAPTER - 3 ANALYTICAL PROFILE 3.1 Estimation of Drug in Pharmaceutical Formulation 3.1.1 Estimation of Drugs ANALYTICAL PROFILE 84 3.1 ESTIMATION OF DRUG IN PHARMACEUTICAL FORMULATION. Agrawal A et al
More informationKetorolac tromethamine (KT)[1] is
RESEARCH ARTICLE Derivative and Simultaneous Equation Methods for the Determination of Fluorometholone and Ketorolac in Ophthalmic Preparations Chandaka Prasanna Kumar*, Bulusu Ravi Teja, Bhupathiraju
More informationEnhancement of Solubility and Dissolution Rate of Poorly Soluble Antihypertensive Drug using Solid Dispersion Technique
ORIGINAL ARTICLE Enhancement of Solubility and Dissolution Rate of Poorly Soluble Antihypertensive Drug using Solid Dispersion Technique Srinivasa Rao Yarraguntla 1, Veeraiah Enturi 2, Ramakrishna Vyadana
More informationRESEARCH ARTICAL PREPARATION AND CHARACTERIZATION OF SELF EMULSIFYING DRUG DELIVERY SYSTEM OF TELMISARTAN
Available Online at www.pharmacia.ipsgwalior.org ISSN. No. 2229-4309 (Online), Vol. 3, Issue 1, July 2016 Pharmacia: An International Journal of Pharmaceutical Sciences RESEARCH ARTICAL PREPARATION AND
More informationThe Nitrofurantoin Capsules Revision Bulletin supersedes the currently official monograph.
Nitrofurantoin Capsules Type of Posting Revision Bulletin Posting Date 25 May 2018 Official Date 01 Jun 2018 Expert Committee Chemical Medicines Monographs 1 Reason for Revision Compliance In accordance
More informationPreparation, Characterization, and Evaluation of Physical Mixtures of Ibuprofen for Solubility Enhancement
Human Journals Research Article December 2017 Vol.:11, Issue:1 All rights are reserved by Juti Rani Devi et al. Preparation, Characterization, and Evaluation of Physical Mixtures of for Solubility Enhancement
More informationDissolution study and method validation of alprazolam by high performance liquid chromatography method in pharmaceutical dosage form
Research Journal of Recent Sciences ISSN 2277-252 Dissolution study and method validation of alprazolam by high performance liquid chromatography method in pharmaceutical dosage form Abstract Rele Rajan
More informationPHARMA SCIENCE MONITOR FORMULATION AND EVALUATION OF SOLID DISPERSION OF OLANZEPINE
PHARMA SCIENCE MONITOR AN INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES FORMULATION AND EVALUATION OF SOLID DISPERSION OF OLANZEPINE Patel Chirag*, Sahoo Ujwal, Seth A.K., Shah Viral, Upadhyay Umesh
More informationPelagia Research Library
Available online at www.pelagiaresearchlibrary.com Der Pharmacia Sinica, 2012, 3 (1):111-116 ISSN: 0976-8688 CODEN (USA): PSHIBD Formulation and Evaluation of Pseudoephedrine hydrochloride Extended Release
More information